• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估肌球蛋白结合蛋白 C 结构域 C2 的热力学和力学不稳定性对致肥厚型心肌病双突变的发病机制的贡献。

Assessment of the Contribution of a Thermodynamic and Mechanical Destabilization of Myosin-Binding Protein C Domain C2 to the Pathomechanism of Hypertrophic Cardiomyopathy-Causing Double Mutation .

机构信息

Fritz Hartmann Centre for Medical Research, Institute for Biophysical Chemistry, Hannover Medical School, Carl Neuberg Str. 1, D-30625 Hannover, Germany.

Division for Structural Biochemistry, Hannover Medical School, Carl Neuberg Str. 1, D-30625 Hannover, Germany.

出版信息

Int J Mol Sci. 2021 Nov 4;22(21):11949. doi: 10.3390/ijms222111949.

DOI:10.3390/ijms222111949
PMID:34769381
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8584774/
Abstract

Mutations in the gene encoding cardiac myosin-binding protein-C (MyBPC), a thick filament assembly protein that stabilizes sarcomeric structure and regulates cardiac function, are a common cause for the development of hypertrophic cardiomyopathy. About 10% of carriers of the Δ25bp variant of , which is common in individuals from South Asia, are also carriers of the D389V variant on the same allele. Compared with noncarriers and those with alone, indicators for the development of hypertrophic cardiomyopathy occur with increased frequency in carriers. Residue D389 lies in the IgI-like C2 domain that is part of the N-terminal region of MyBPC. To probe the effects of mutation D389V on structure, thermostability, and protein-protein interactions, we produced and characterized wild-type and mutant constructs corresponding to the isolated 10 kDa C2 domain and a 52 kDa N-terminal fragment that includes subdomains C0 to C2. Our results show marked reductions in the melting temperatures of D389V mutant constructs. Interactions of construct C0-C2 D389V with the cardiac isoforms of myosin-2 and actin remain unchanged. Molecular dynamics simulations reveal changes in the stiffness and conformer dynamics of domain C2 caused by mutation D389V. Our results suggest a pathomechanism for the development of HCM based on the toxic buildup of misfolded protein in young carriers that is supplanted and enhanced by C-zone haploinsufficiency at older ages.

摘要

编码心肌肌球蛋白结合蛋白 C(MyBPC)的基因突变是肥厚型心肌病发展的常见原因。MyBPC 是一种稳定肌节结构和调节心脏功能的粗丝组装蛋白,在南亚人群中常见的 Δ25bp 变异的约 10%携带者也是同一等位基因上 D389V 变异的携带者。与非携带者和仅携带 者相比,肥厚型心肌病发展的指标在 携带者中更频繁地发生。残基 D389 位于 IgI 样 C2 结构域内,该结构域是 MyBPC N 端区域的一部分。为了探究突变 D389V 对结构、热稳定性和蛋白-蛋白相互作用的影响,我们制备并表征了相应的野生型和突变型构建体,这些构建体分别对应于分离的 10 kDa C2 结构域和包含亚结构域 C0 至 C2 的 52 kDa N 端片段。我们的结果表明,D389V 突变构建体的熔点明显降低。与肌球蛋白-2 和肌动蛋白的心脏同工型的 C0-C2 D389V 构建体的相互作用保持不变。分子动力学模拟揭示了突变 D389V 引起的结构域 C2 的刚性和构象动力学变化。我们的结果表明,基于年轻的 携带者中错误折叠蛋白的毒性积累导致 HCM 发展的发病机制,该机制在老年时被 C 区单倍不足所取代和增强。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/8584774/4fbeb0bb7840/ijms-22-11949-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/8584774/bd47f9165b2f/ijms-22-11949-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/8584774/d9e0290ae81f/ijms-22-11949-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/8584774/2c2138f119a3/ijms-22-11949-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/8584774/8472938b9ee6/ijms-22-11949-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/8584774/fc7f390840ce/ijms-22-11949-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/8584774/7954471f570f/ijms-22-11949-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/8584774/4fbeb0bb7840/ijms-22-11949-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/8584774/bd47f9165b2f/ijms-22-11949-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/8584774/d9e0290ae81f/ijms-22-11949-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/8584774/2c2138f119a3/ijms-22-11949-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/8584774/8472938b9ee6/ijms-22-11949-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/8584774/fc7f390840ce/ijms-22-11949-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/8584774/7954471f570f/ijms-22-11949-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/8584774/4fbeb0bb7840/ijms-22-11949-g007.jpg

相似文献

1
Assessment of the Contribution of a Thermodynamic and Mechanical Destabilization of Myosin-Binding Protein C Domain C2 to the Pathomechanism of Hypertrophic Cardiomyopathy-Causing Double Mutation .评估肌球蛋白结合蛋白 C 结构域 C2 的热力学和力学不稳定性对致肥厚型心肌病双突变的发病机制的贡献。
Int J Mol Sci. 2021 Nov 4;22(21):11949. doi: 10.3390/ijms222111949.
2
D389V Variant Induces Hypercontractility in Cardiac Organoids.D389V变异体在心脏类器官中诱导过度收缩。
bioRxiv. 2024 May 30:2024.05.29.596463. doi: 10.1101/2024.05.29.596463.
3
Hypertrophic cardiomyopathy-linked variants of cardiac myosin-binding protein C3 display altered molecular properties and actin interaction.肥厚型心肌病相关变体的心肌肌球蛋白结合蛋白 C3 显示出改变的分子特性和肌动蛋白相互作用。
Biochem J. 2018 Dec 14;475(24):3933-3948. doi: 10.1042/BCJ20180685.
4
Association of Cardiomyopathy With MYBPC3 D389V and MYBPC3Δ25bpIntronic Deletion in South Asian Descendants.南亚裔人群中心肌病与 MYBPC3 D389V 和 MYBPC3Δ25bp 内含子缺失的相关性。
JAMA Cardiol. 2018 Jun 1;3(6):481-488. doi: 10.1001/jamacardio.2018.0618.
5
Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice.MYBPC3单倍剂量不足会加剧杂合子小鼠肥厚型心肌病的发展。
J Mol Cell Cardiol. 2015 Feb;79:234-43. doi: 10.1016/j.yjmcc.2014.11.018. Epub 2014 Nov 25.
6
Impact of disease-causing mutations on inter-domain interactions in cMyBP-C: a steered molecular dynamics study.肌球蛋白结合蛋白 C 中致病变异对结构域间相互作用的影响:定向分子动力学研究。
J Biomol Struct Dyn. 2017 Jul;35(9):1916-1922. doi: 10.1080/07391102.2016.1199329. Epub 2016 Jun 30.
7
Mutations in myosin S2 alter cardiac myosin-binding protein-C interaction in hypertrophic cardiomyopathy in a phosphorylation-dependent manner.肌球蛋白 S2 的突变以磷酸化依赖的方式改变肥厚型心肌病中心肌球蛋白结合蛋白-C 的相互作用。
J Biol Chem. 2021 Jul;297(1):100836. doi: 10.1016/j.jbc.2021.100836. Epub 2021 May 27.
8
An Investigation of the Molecular Mechanism of Double cMyBP-C Mutation in a Patient with End-Stage Hypertrophic Cardiomyopathy.终末期肥厚型心肌病患者双cMyBP-C突变分子机制的研究
J Cardiovasc Transl Res. 2015 Jun;8(4):232-43. doi: 10.1007/s12265-015-9624-6. Epub 2015 May 14.
9
Genetic, clinical, molecular, and pathogenic aspects of the South Asian-specific polymorphic MYBPC3 variant.南亚特异性多态性MYBPC3变体的遗传、临床、分子和致病方面
Biophys Rev. 2020 Aug;12(4):1065-1084. doi: 10.1007/s12551-020-00725-1. Epub 2020 Jul 12.
10
Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy.蛋白杂合不足驱动子鉴定出导致肥厚型心肌病的 MYBPC3 变异体。
J Biol Chem. 2021 Jul;297(1):100854. doi: 10.1016/j.jbc.2021.100854. Epub 2021 Jun 5.

引用本文的文献

1
Disparate Molecular Properties of Two Hypertrophic Cardiomyopathy-Associated cMyBP-C Mutants Reveal Distinct Pathogenic Mechanisms Beyond Haploinsufficiency.两种肥厚型心肌病相关的心肌肌球蛋白结合蛋白C(cMyBP-C)突变体的不同分子特性揭示了单倍体不足之外的独特致病机制。
Biomedicines. 2025 Apr 22;13(5):1010. doi: 10.3390/biomedicines13051010.
2
Experience using conventional compared to ancestry-based population descriptors in clinical genomics laboratories.临床基因组学实验室中使用传统人群描述符与基于血统的人群描述符的经验。
Am J Hum Genet. 2025 Mar 6;112(3):481-491. doi: 10.1016/j.ajhg.2025.01.008. Epub 2025 Jan 29.
3
Machine learning-driven diagnostic signature provides new insights in clinical management of hypertrophic cardiomyopathy.

本文引用的文献

1
CORE-MD II: A fast, adaptive, and accurate enhanced sampling method.CORE-MD II:一种快速、自适应且精确的增强采样方法。
J Chem Phys. 2021 Sep 14;155(10):104114. doi: 10.1063/5.0063664.
2
Nanomechanical Phenotypes in Cardiac Myosin-Binding Protein C Mutants That Cause Hypertrophic Cardiomyopathy.心肌肌球蛋白结合蛋白 C 突变导致肥厚型心肌病的纳米力学表型。
ACS Nano. 2021 Jun 22;15(6):10203-10216. doi: 10.1021/acsnano.1c02242. Epub 2021 Jun 1.
3
Mutations in myosin S2 alter cardiac myosin-binding protein-C interaction in hypertrophic cardiomyopathy in a phosphorylation-dependent manner.
机器学习驱动的诊断特征为肥厚型心肌病的临床管理提供了新的见解。
ESC Heart Fail. 2024 Aug;11(4):2234-2248. doi: 10.1002/ehf2.14762. Epub 2024 Apr 17.
4
Mechanisms of Sarcomere Protein Mutation-Induced Cardiomyopathies.肌节蛋白突变诱导的心肌病的发病机制。
Curr Cardiol Rep. 2023 Jun;25(6):473-484. doi: 10.1007/s11886-023-01876-9. Epub 2023 Apr 15.
肌球蛋白 S2 的突变以磷酸化依赖的方式改变肥厚型心肌病中心肌球蛋白结合蛋白-C 的相互作用。
J Biol Chem. 2021 Jul;297(1):100836. doi: 10.1016/j.jbc.2021.100836. Epub 2021 May 27.
4
Myosin-18B Regulates Higher-Order Organization of the Cardiac Sarcomere through Thin Filament Cross-Linking and Thick Filament Dynamics.肌球蛋白-18B通过细肌丝交联和粗肌丝动力学调节心肌肌节的高级组织。
Cell Rep. 2020 Sep 1;32(9):108090. doi: 10.1016/j.celrep.2020.108090.
5
Spatial and Functional Distribution of Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy.肥厚型心肌病患者致病性变异体的空间和功能分布及临床结局。
Circ Genom Precis Med. 2020 Oct;13(5):396-405. doi: 10.1161/CIRCGEN.120.002929. Epub 2020 Aug 25.
6
Scalable molecular dynamics on CPU and GPU architectures with NAMD.使用 NAMD 在 CPU 和 GPU 架构上进行可扩展的分子动力学。
J Chem Phys. 2020 Jul 28;153(4):044130. doi: 10.1063/5.0014475.
7
South Asian-Specific Intronic Deletion and Its Role in Cardiomyopathies and Heart Failure.南亚特异性内含子缺失及其在心肌病和心力衰竭中的作用。
Circ Genom Precis Med. 2020 Jun;13(3):e002986. doi: 10.1161/CIRCGEN.120.002986. Epub 2020 Jun 16.
8
Protein Thermodynamic Destabilization in the Assessment of Pathogenicity of a Variant of Uncertain Significance in Cardiac Myosin Binding Protein C.心脏肌球蛋白结合蛋白 C 中意义不确定变体致病性评估中的蛋白质热力学不稳定性。
J Cardiovasc Transl Res. 2020 Oct;13(5):867-877. doi: 10.1007/s12265-020-09959-6. Epub 2020 Feb 7.
9
MyBP-C: one protein to govern them all.MyBP-C:一统天下的蛋白。
J Muscle Res Cell Motil. 2020 Mar;41(1):91-101. doi: 10.1007/s10974-019-09567-1. Epub 2020 Jan 20.
10
Single molecule mechanics resolves the earliest events in force generation by cardiac myosin.单分子力学解析了心肌球蛋白产生力的最早事件。
Elife. 2019 Sep 17;8:e49266. doi: 10.7554/eLife.49266.